Sign in to view content

What Happens to Diabetic Retinopathy Severity Scores With Less Aggressive Treatment? A Post Hoc Analysis of the RISE and RIDE Open Label Extension Study

Roger A. Goldberg, MD, MBA

Video
Published 2019

Roger A. Goldberg, MD, MBA, interviewed by Ratimir Lazic, MD, PhD

Related

Diabetic Retinopathy Lesion Types and Distribution on Ultra-Widefield Imaging and the Risk for Disease Worsening Over Time
Paolo Antonio S. Silva, MD
Annual Meeting Talks
2024
Relationships Between Total Retinal Volume and Visual and Anatomic Outcome Measures in Patients With Diabetic Macular Edema in RIDE and RISE
Michelle V. Carle, MD. MMEd
On Demand Cases, Courses, and Papers
2019
What Is the Clinical Significance of Improving Diabetic Retinopathy for Vision Outcomes? A Meta-Analysis of 5 Ranibizumab Trials
Sophie Jane Bakri, MD
Annual Meeting Talks
2021

Category: Diabetic Retinopathy

See more